Prolonged respiratory disorder predicts adverse prognosis in infants with end-stage kidney disease

被引:1
|
作者
Sakai, Tomoyuki [1 ]
Murakami, Yoshitaka [2 ]
Okuda, Yusuke [1 ]
Hamada, Riku [3 ]
Hamasaki, Yuko [4 ]
Ishikura, Kenji [5 ]
Hataya, Hiroshi [3 ]
Honda, Masataka [3 ]
机构
[1] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 5202192, Japan
[2] Toho Univ, Fac Med, Dept Med Stat, Tokyo, Japan
[3] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Tokyo, Japan
[4] Toho Univ, Fac Med, Dept Pediat Nephrol, Tokyo, Japan
[5] Natl Ctr Child Hlth & Dev, Div Nephrol & Rheumatol, Tokyo, Japan
关键词
End-stage kidney disease; Infant; Peritoneal dialysis; Pulmonary hypoplasia; Survival analysis; Withholding treatment; INHALED NITRIC-OXIDE; RENAL-DISEASE; PERITONEAL-DIALYSIS; PULMONARY HYPOPLASIA; NEONATAL-PERIOD; CHILDREN; OLIGOHYDRAMNIOS; OUTCOMES; SURVIVAL; THERAPY;
D O I
10.1007/s00467-016-3430-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Among comorbidities, pulmonary hypoplasia (PH) is known as a significant risk factor for mortality in infants with end-stage kidney disease (ESKD). However, the final outcomes of infants with both ESKD and PH are still not well defined, as the diagnosis modality, and definition of PH severity remain ambiguous. Methods Children initiating peritoneal dialysis during infancy from 1990 to 2015 were followed until death, date of last contact, or the end of 2015. We examined the long-term outcome of children with congenital pulmonary disorders by studying infants with prolonged respiratory disorders of greater than 28 days duration after birth and evaluated risk factors for mortality. Results Forty-six children were followed (median follow-up, 9.23 years), and classified as children without (n = 38; Group A) or with (n = 8; Group B) a prolonged respiratory disorder. Overall actuarial 5 year survival rate in this cohort was 79.5 %. The survival curve in Group B showed a significant decline compared with Group A. Prolonged respiratory disorder was significantly associated with mortality by multivariate analysis (hazard ratio, 8.32). Conclusions Infants who initiate peritoneal dialysis complicated by prolonged respiratory disorders have increased adverse risk factors for mortality; therefore, withholding aggressive treatment should be considered.
引用
收藏
页码:2127 / 2136
页数:10
相关论文
共 50 条
  • [21] Lupus Nephritis and End-stage Kidney Disease
    Maroz, Natallia
    Segal, Mark S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 346 (04) : 319 - 323
  • [22] Glycosylation and Characterization of Human Transferrin in an End-Stage Kidney Disease
    Miljus, Goran
    Penezic, Ana
    Pazitna, Lucia
    Gligorijevic, Nikola
    Baralic, Marko
    Vilotic, Aleksandra
    Sunderic, Milos
    Robajac, Dragana
    Dobrijevic, Zorana
    Katrlik, Jaroslav
    Nedic, Olgica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [23] Cancer Screening in End-Stage Kidney Disease
    Shirazian, Shayan
    Starakiewicz, Piotr
    Latcha, Sheron
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2021, 28 (05) : 502 - +
  • [24] Global case studies for chronic kidney disease/end-stage kidney disease care
    Yang, Chih-Wei
    Harris, David C. H.
    Luyckx, Valerie A.
    Nangaku, Masaomi
    Hou, Fan Fan
    Garcia, Guillermo Garcia
    Abu-Aisha, Hasan
    Niang, Abdou
    Sola, Laura
    Bunnag, Sakarn
    Eiam-Ong, Somchai
    Tungsanga, Kriang
    Richards, Marie
    Richards, Nick
    Goh, Bak Leong
    Dreyer, Gavin
    Evans, Rhys
    Mzingajira, Henry
    Twahir, Ahmed
    McCulloch, Mignon I.
    Ahn, Curie
    Osafo, Charlotte
    Hsu, Hsiang-Hao
    Barnieh, Lianne
    Donner, Jo-Ann
    Tonelli, Marcello
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2020, 10 (01) : E24 - E48
  • [25] Single-Center Experience on Growth in Infants Born With End-Stage Kidney Disease
    Slagle, Cara L.
    Riddle, Stefanie L.
    McNelis, Kera
    Claes, Donna
    JOURNAL OF RENAL NUTRITION, 2023, 33 (02) : 236 - 242
  • [26] Adolescents and Young Adults with Chronic or End-Stage Kidney Disease
    Ferris, Maria E.
    Miles, J. Alexander
    Seamon, Meredith L.
    BLOOD PURIFICATION, 2016, 41 (1-3) : 205 - 210
  • [27] A systematic review and quality assessment of economic evaluations of kidney replacement therapies in end-stage kidney disease
    Nyokabi, Patricia
    Youngkong, Sitaporn
    Bagepally, Bhavani Shankara
    Okech, Tabitha
    Chaikledkaew, Usa
    McKay, Gareth J.
    Attia, John
    Thakkinstian, Ammarin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [28] Economic evaluation of peritoneal dialysis and hemodialysis in Thai population with End-stage Kidney Disease
    Assanatham, Montira
    Pattanaprateep, Oraluck
    Chuasuwan, Anan
    Vareesangthip, Kriengsak
    Supasyndh, Ouppatham
    Lumpaopong, Adisorn
    Susantitaphong, Paweena
    Limkunakul, Chutatip
    Ponthongmak, Wanchana
    Chaiyakittisopon, Kamolpat
    Thakkinstian, Ammarin
    Ingsathit, Atiporn
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [29] Treatment Patterns for End-Stage Kidney Failure in Patients With Systemic Lupus Erythematous
    Lao, Chunhuan
    Van Dantzig, Philippa
    Rabindranath, Kannaiyan
    White, Douglas
    Lawrenson, Ross
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2024, 30 (05) : 183 - 187
  • [30] Peritoneal dialysis catheter outcomes in infants initiating peritoneal dialysis for end-stage renal disease
    Imani, Peace D.
    Carpenter, Jennifer L.
    Bell, Cynthia S.
    Brandt, Mary L.
    Braun, Michael C.
    Swartz, Sarah J.
    BMC NEPHROLOGY, 2018, 19